INDRENEW stock news
This page provides real-time market news, earnings updates, and company announcements related to IND Renewable Energy Ltd (INDRENEW).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-27 02:25 IST
Old National Bancorp Announces Increases to Quarterly Common Stock Dividend and Share Repurchase Program
Finviz2026-02-19 14:03:34
Where is Janux Therapeutics (JANX) Headed According to Analysts?
Finviz2026-02-19 15:00:26
Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference
Finviz2026-02-20 13:03:08
PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval
Finviz2026-02-20 13:33:46
Merck vs. Bristol Myers: Which Pharma Stock Is a Better Pick in 2026?
Finviz2026-02-20 18:06:38
Dare Bioscience Announces FDA Clearance of IND for Phase 2 Clinical Study of DARE-HPV, a Potential Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer
Finviz2026-02-23 13:03:44
MBX Biosciences to Participate in Upcoming March Investor Conferences
Finviz2026-02-23 13:03:48
Akari Therapeutics Appoints Globally Recognized Expert in RNA Biology and Cancer Research, Olga Anczukow, Ph.D., to its Scientific Advisory Board
Finviz2026-02-23 13:54:10
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
Finviz2026-02-23 16:03:11
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-02-24 12:09:09
BioRestorative Expands Global Protection for ThermoStem, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs
Finviz2026-02-24 13:33:08
What's Going On With Beam Therapeutics Stock?
Finviz2026-02-24 19:12:43
BridgeBio Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial Updates
Finviz2026-02-24 21:06:47
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-24 21:33:11
Immuron Reports HY26 Results and Strategic Reset
Finviz2026-02-25 11:03:09
Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
Finviz2026-02-25 13:00:55
Curanex Provides Operational Update on Key Regulatory Milestones
Finviz2026-02-25 13:03:48
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-25 21:09:44
Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Finviz2026-02-26 12:03:47
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Finviz2026-02-26 12:33:48
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-02-26 14:06:40
ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance
Finviz2026-02-26 16:57:15
Merck vs. Bristol Myers: Which Pharma Stock Is a Better Pick in 2026?
Finviz2026-02-20 18:06:38
Dare Bioscience Announces FDA Clearance of IND for Phase 2 Clinical Study of DARE-HPV, a Potential Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer
Finviz2026-02-23 13:03:44
MBX Biosciences to Participate in Upcoming March Investor Conferences
Finviz2026-02-23 13:03:48
Akari Therapeutics Appoints Globally Recognized Expert in RNA Biology and Cancer Research, Olga Anczukow, Ph.D., to its Scientific Advisory Board
Finviz2026-02-23 13:54:10
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
Finviz2026-02-23 16:03:11
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-02-24 12:09:09
BioRestorative Expands Global Protection for ThermoStem, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs
Finviz2026-02-24 13:33:08
What's Going On With Beam Therapeutics Stock?
Finviz2026-02-24 19:12:43
BridgeBio Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial Updates
Finviz2026-02-24 21:06:47
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-24 21:33:11
Immuron Reports HY26 Results and Strategic Reset
Finviz2026-02-25 11:03:09
Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
Finviz2026-02-25 13:00:55
Curanex Provides Operational Update on Key Regulatory Milestones
Finviz2026-02-25 13:03:48
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-25 21:09:44
Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Finviz2026-02-26 12:03:47
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Finviz2026-02-26 12:33:48
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-02-26 14:06:40
ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance
Finviz2026-02-26 16:57:15
INDRENEW stock price change
On the last trading day, INDRENEW stock closed at 11.50 INR, with a price change of -2.46% for the day.
Trade stock perpsINDRENEW stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more